World Journal of Surgery

, Volume 39, Issue 1, pp 237–243 | Cite as

Safe Hepatectomy Selection Criteria for Hepatocellular Carcinoma Patients: A Validation of 336 Consecutive Hepatectomies. The BILCHE Score

  • Matteo Donadon
  • Guido Costa
  • Matteo Cimino
  • Fabio Procopio
  • Daniele Del Fabbro
  • Angela Palmisano
  • Guido TorzilliEmail author
Original Scientific Report



Selection criteria for hepatectomy for hepatocellular carcinoma (HCC) are object of debate. We presented our criteria for safe hepatectomy for HCC, and we compared the results with those obtainable using the most common scores for HCC.


All patients submitted to hepatectomy for HCC based on the same criteria were reviewed from our prospectively maintained database. Such criteria included bilirubin (BIL), cholinesterases (CHE), ascites, esophageal varices, and residual liver volume.


A total of 336 patients were analyzed. One hundred fifteen patients (33 %) had thoracoabdominal approach, but only 39 (12 %) had major or extended resections. The median tumor number was 1 (range 1–33), while the median tumor size was 3.6 cm (range 1.1–28). Of those, 94 (29 %) had postoperative complications, of which 6 % were graded as major (Dindo III–IV). The 90-days mortality was 2 %. The MELD, APRI, and CPT scores were not found to be statistically significant for complications, while combining BIL and CHE we defined four classes of risk. The association of BIL >1 mg/dl (>17.1 µmol/l) and CHE ≤5,900 U/l was the best to detect complications (OR = 4.45; P = 0.007).


This study shows that our selection criteria that count mainly on two commonly available, and inexpensive parameters, BIL and CHE, lead to identify patients potentially at risk of postoperative complications after hepatic resection for HCC. Registration number: NCT02056041 (


Hepatic Resection Transjugular Intrahepatic Portosystemic Shunt Esophageal Varix Portal Vein Embolization Postoperative Liver Failure 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    El-Serag HB (2007) Epidemiology of hepatocellular carcinoma in USA. Hepatol Res 37(Suppl 2):88–94CrossRefGoogle Scholar
  2. 2.
    Mazzaferro V, Regalia E, Doci R et al (1996) Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 334(11):693–699PubMedCrossRefGoogle Scholar
  3. 3.
    Duffy JP, Hiatt JR, Busuttil RW (2008) Surgical resection of hepatocellular carcinoma. Cancer J 14(2):100–110PubMedCrossRefGoogle Scholar
  4. 4.
    Torzilli G, Belghiti J, Kokudo N et al (2013) A snapshot of the effective indications and results of surgery for hepatocellular carcinoma in tertiary referral centers: is it adherent to the EASL/AASLD recommendations?: an observational study of the HCC East-West study group. Ann Surg 257(5):929–937PubMedCrossRefGoogle Scholar
  5. 5.
    Kubota K, Makuuchi M, Kusaka K et al (1997) Measurement of liver volume and hepatic functional reserve as a guide to decision-making in resectional surgery for hepatic tumors. Hepatology 26(5):1176–1181PubMedGoogle Scholar
  6. 6.
    Shindoh J, CW DT, Vauthey JN (2012) Portal vein embolization for hepatocellular carcinoma. Liver Cancer 1(3–4):159–167Google Scholar
  7. 7.
    Torzilli G, Makuuchi M, Inoue K et al (1999) No-mortality liver resection for hepatocellular carcinoma in cirrhotic and noncirrhotic patients: is there a way? A prospective analysis of our approach. Arch Surg 134(9):984–992PubMedCrossRefGoogle Scholar
  8. 8.
    Pugh RN, Murray-Lyon IM, Dawson JL et al (1973) Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 60(8):646–649PubMedCrossRefGoogle Scholar
  9. 9.
    Ichikawa T, Uenishi T, Takemura S et al (2009) A simple, noninvasively determined index predicting hepatic failure following liver resection for hepatocellular carcinoma. J Hepatobiliary Pancreat Surg 16(1):42–48PubMedCrossRefGoogle Scholar
  10. 10.
    Cucchetti A, Ercolani G, Vivarelli M et al (2006) Impact of model for end-stage liver disease (MELD) score on prognosis after hepatectomy for hepatocellular carcinoma on cirrhosis. Liver Transpl 12(6):966–971PubMedCrossRefGoogle Scholar
  11. 11.
    Torzilli G, Donadon M, Marconi M et al (2008) Hepatectomy for stage B and stage C hepatocellular carcinoma in the Barcelona Clinic Liver Cancer classification: results of a prospective analysis. Arch Surg 143(11):1082–1090PubMedCrossRefGoogle Scholar
  12. 12.
    Donadon M, Cimino M, Procopio F et al (2013) Potential role of cholinesterases to predict short-term outcome after hepatic resection for hepatocellular carcinoma. Updates Surg 65(1):11–18PubMedCrossRefGoogle Scholar
  13. 13.
    Malinchoc M, Kamath PS, Gordon FD et al (2000) A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology 31(4):864–871PubMedCrossRefGoogle Scholar
  14. 14.
    Belghiti J, Clavien P, Gadzijev E et al (2000) The Brisbane 2000 terminology of liver anatomy and resections. HPB (Oxford) 2(3):333–339Google Scholar
  15. 15.
    Dindo D, Demartines N, Clavien PA (2004) Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 240(2):205–213PubMedCentralPubMedCrossRefGoogle Scholar
  16. 16.
    Imamura H, Seyama Y, Kokudo N et al (2003) One thousand fifty-six hepatectomies without mortality in 8 years. Arch Surg 138(11):1198–1206; discussion 1206Google Scholar
  17. 17.
    Llovet JM, Bru C, Bruix J (1999) Prognosis of hepatocellular carcinoma: the BCLC staging classification. Semin Liver Dis 19(3):329–338PubMedCrossRefGoogle Scholar
  18. 18.
    Oken MM, Creech RH, Tormey DC et al (1982) Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 5(6):649–655PubMedCrossRefGoogle Scholar
  19. 19.
    (1980) The general rules for recording endoscopic findings on esophageal varices. Jpn J Surg 10(1):84-87Google Scholar
  20. 20.
    Torzilli G (2014) Ultrasound-Guided Liver Surgery: An Atlas, Springer-Verlag, MilanGoogle Scholar
  21. 21.
    Donadon M, Costa G, Gatti A et al (2014) Thoracoabdominal approach in liver surgery: how, when, and why. Updates Surg 66(2):121–125PubMedCrossRefGoogle Scholar
  22. 22.
    Torzilli G, Olivari N, Del Fabbro D et al (2005) Bilirubin level fluctuation in drain discharge after hepatectomies justifies long-term drain maintenance. Hepatogastroenterology 52(64):1206–1210PubMedGoogle Scholar
  23. 23.
    Torzilli G, Gambetti A, Del Fabbro D et al (2004) Techniques for hepatectomies without blood transfusion, focusing on interpretation of postoperative anemia. Arch Surg 139(10):1061–1065PubMedCrossRefGoogle Scholar
  24. 24.
    Wai CT, Greenson JK, Fontana RJ et al (2003) A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatology 38(2):518–526PubMedCrossRefGoogle Scholar
  25. 25.
    Schroeder RA, Marroquin CE, Bute BP et al (2006) Predictive indices of morbidity and mortality after liver resection. Ann Surg 243(3):373–379PubMedCentralPubMedCrossRefGoogle Scholar
  26. 26.
    Teh SH, Christein J, Donohue J et al (2005) Hepatic resection of hepatocellular carcinoma in patients with cirrhosis: model of end-stage liver disease (MELD) score predicts perioperative mortality. J Gastrointest Surg 9(9):1207–1215; discussion 1215Google Scholar
  27. 27.
    Makuuchi M, Kosuge T, Takayama T et al (1993) Surgery for small liver cancers. Semin Surg Oncol 9(4):298–304PubMedCrossRefGoogle Scholar
  28. 28.
    Bruix J, Sherman M (2011) Management of hepatocellular carcinoma: an update. Hepatology 53(3):1020–1022PubMedCentralPubMedCrossRefGoogle Scholar
  29. 29.
    Bruix J, Sherman M, Llovet JM et al (2001) Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. J Hepatol 35(3):421–430PubMedCrossRefGoogle Scholar
  30. 30.
    Kamath PS, Wiesner RH, Malinchoc M et al (2001) A model to predict survival in patients with end-stage liver disease. Hepatology 33(2):464–470PubMedCrossRefGoogle Scholar
  31. 31.
    Lin ZH, Xin YN, Dong QJ et al (2011) Performance of the aspartate aminotransferase-to-platelet ratio index for the staging of hepatitis C-related fibrosis: an updated meta-analysis. Hepatology 53(3):726–736PubMedCrossRefGoogle Scholar
  32. 32.
    Belghiti J, Ogata S (2005) Assessment of hepatic reserve for the indication of hepatic resection. J Hepatobiliary Pancreat Surg 12(1):1–3PubMedCrossRefGoogle Scholar
  33. 33.
    Ishizawa T, Hasegawa K, Kokudo N et al (2009) Risk factors and management of ascites after liver resection to treat hepatocellular carcinoma. Arch Surg 144(1):46–51PubMedCrossRefGoogle Scholar
  34. 34.
    Mayo SC, Shore AD, Nathan H et al (2011) Refining the definition of perioperative mortality following hepatectomy using death within 90 days as the standard criterion. HPB (Oxford) 13(7):473–482CrossRefGoogle Scholar
  35. 35.
    Bruix J, Castells A, Bosch J et al (1996) Surgical resection of hepatocellular carcinoma in cirrhotic patients: prognostic value of preoperative portal pressure. Gastroenterology 111(4):1018–1022PubMedCrossRefGoogle Scholar
  36. 36.
    Peduzzi P, Concato J, Feinstein AR et al (1995) Importance of events per independent variable in proportional hazards regression analysis. II. Accuracy and precision of regression estimates. J Clin Epidemiol 48(12):1503–1510PubMedCrossRefGoogle Scholar

Copyright information

© Société Internationale de Chirurgie 2014

Authors and Affiliations

  • Matteo Donadon
    • 1
  • Guido Costa
    • 1
  • Matteo Cimino
    • 1
  • Fabio Procopio
    • 1
  • Daniele Del Fabbro
    • 1
  • Angela Palmisano
    • 1
  • Guido Torzilli
    • 1
    Email author
  1. 1.Department of Hepatobiliary Surgery, Humanitas Research HospitalUniversity of Milan School of MedicineRozzanoItaly

Personalised recommendations